Insider · CIK 0001806384

Mosseri Marlio Charles

Reports to the SEC for 1 company · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001806384

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+50K sh	$18.32	+$916K	3,186,576
2025-10-27	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+72.8K sh	$6.28	+$457K	3,136,576
2025-10-24	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+35K sh	$6.15	+$215K	3,063,740
2025-10-23	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+46.9K sh	$6.06	+$284K	3,028,706
2025-06-20	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+5,603 sh	$7.99	+$44.8K	2,981,806
2025-06-18	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+28K sh	$8.05	+$226K	2,976,203
2025-06-17	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+5,399 sh	$8.11	+$43.8K	2,948,160
2025-05-12	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+21.2K sh	$8.11	+$172K	2,942,761
2025-05-09	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+5,395 sh	$8.98	+$48.4K	2,936,594
2025-05-09	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+9,850 sh	$8.95	+$88.1K	2,921,382
2025-05-09	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+9,817 sh	$8.90	+$87.4K	2,931,199
2025-05-08	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+100 sh	$8.65	+$865	2,909,132
2025-05-08	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+2,400 sh	$8.65	+$20.8K	2,911,532
2025-05-08	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+100 sh	$8.99	+$899	2,909,032
2025-05-08	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+100 sh	$8.71	+$871	2,909,132
2025-05-08	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+2,400 sh	$8.97	+$21.5K	2,911,532
2025-05-08	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+50 sh	$8.65	+$432.5	2,908,932
2025-05-08	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+100 sh	$8.65	+$865	2,909,032
2025-05-07	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+2,703 sh	$8.40	+$22.7K	2,899,268
2025-05-07	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+9,614 sh	$8.64	+$83.1K	2,908,882
2025-05-06	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+10.1K sh	$8.64	+$87.3K	2,896,565
2025-05-06	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+2,340 sh	$8.40	+$19.7K	2,886,461
2025-02-07	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+240K sh	$5.00	+$1.2M	2,884,121
2024-12-13	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+17K sh	$4.70	+$79.9K	2,612,000
2024-12-13	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+17K sh	$4.70	+$79.9K	2,644,121
2024-12-12	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+32.1K sh	$4.64	+$149K	2,627,121
2023-07-31	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+860 sh	$13.88	+$11.9K	2,595,000
2023-07-28	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+2,584 sh	$13.91	+$35.9K	2,594,140
2023-07-27	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+1,556 sh	$13.98	+$21.8K	2,591,556
2023-07-26	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+10K sh	$13.97	+$140K	2,590,000
2023-07-21	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+2,844 sh	$14.61	+$41.6K	2,580,000
2023-07-20	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+5,394 sh	$14.40	+$77.7K	2,577,156
2023-07-19	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+8,000 sh	$14.84	+$119K	2,571,762
2023-07-18	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+9,149 sh	$14.84	+$136K	2,563,762
2023-07-12	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+3,285 sh	$15.09	+$49.6K	2,554,613
2023-07-11	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+10K sh	$15.36	+$154K	2,551,328
2023-07-07	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+8,948 sh	$15.19	+$136K	2,541,328
2023-07-06	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+3,179 sh	$15.01	+$47.7K	2,532,380
2023-07-05	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+1,176 sh	$15.52	+$18.3K	2,529,201
2023-06-26	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+16.8K sh	$16.46	+$276K	2,528,025
2023-06-23	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+73.2K sh	$17.43	+$1.28M	2,511,265
2023-06-22	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+6,999 sh	$17.73	+$124K	2,438,090
2023-06-21	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+6,091 sh	$17.71	+$108K	2,431,091
2023-06-16	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+12.7K sh	$17.75	+$225K	2,425,000
2023-06-15	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+400 sh	$17.54	+$7,016	2,380,576
2023-06-15	NVCTNuvectis Pharma, Inc.P Purchase	10% Owner	PPurchase	+31.7K sh	$17.71	+$562K	2,412,300

Recent filings

Accepted (ET)
Jul 14
Mosseri Marlio Charles0001104659-26-079793
SEC(opens sec.gov)
Oct 294
Mosseri Marlio Charles0001104659-25-103522
SEC(opens sec.gov)
Jun 244
Mosseri Marlio Charles0001104659-25-062168
SEC(opens sec.gov)
Jun 204
Mosseri Marlio Charles0001104659-25-060965
SEC(opens sec.gov)
May 134
Mosseri Marlio Charles0001104659-25-047938
SEC(opens sec.gov)
May 124/A
Mosseri Marlio Charles0001104659-25-047089
SEC(opens sec.gov)
May 94
Mosseri Marlio Charles0001104659-25-046882
SEC(opens sec.gov)

Companies

Nuvectis Pharma, Inc.10% OwnerNVCT

Address

27 RIPPLEVALE GROVE

LONDON, N1 1HS